ANTI-CD45 ANTIBODY-DRUG CONJUGATES AS TARGETED CONDITIONING AGENTS FOR TRANSPLANTATION/GENE THERAPY WITH POTENT ANTI-LEUKAEMIC PROPERTIES

被引：0
|
作者：
Liao, Aiyin [1 ]
Yeung, Jenny [1 ,2 ]
Shaw, Matthew [1 ]
Caetano-Silva, Soraia [1 ]
Vetharoy, Winston [1 ]
Kirby, Ian [3 ]
Zammarchi, Francesca [3 ]
van Berkel, Patrick H. [3 ]
Booth, Claire [1 ,4 ]
Gaspar, Bobby [1 ]
Thrasher, Adrian [1 ]
Chester, Kerry [2 ]
Amrolia, Persis J. [1 ,4 ]
机构：
[1] UCL Great Ormond St Inst Child Hlth, London, England
[2] UCL Canc Inst, London, England
[3] ADC Therapeut, London, England
[4] Great Ormond St Hosp Sick Children, London, England
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / SUPP1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
O055
引用
收藏
页码：57 / 58
页数：2
相关论文
共 50 条
  • [1] Development of Anti-CD45 Antibody Drug Conjugates As Targeted Conditioning Agents for Transplantation/Gene Therapy with Potent Anti-Leukemic Properties
    Yeung, Jenny
    Liao, Aiyin
    Shaw, Matthew
    Caetano-Silva, Soraia
    Vetharoy, Winston
    Kirby, Ian
    Zammarchi, Francesca
    Havenith, Karin
    van Berkel, Patrick H.
    Booth, Claire
    Gaspar, H. Bobby
    Thrasher, Adrian J.
    Chester, Kerry
    Amrolia, Persis J.
    [J]. BLOOD, 2022, 140 : 10211 - 10212
  • [2] Anti-CD45 PBD-based antibody-drug conjugates are effective targeted conditioning agents for gene therapy and stem cell transplant
    Yeung, Jenny
    Liao, Aiyin
    Shaw, Matthew
    Silva, Soraia
    Vetharoy, Winston
    Rico, Diego Leon
    Kirby, Ian
    Zammarchi, Francesca
    Havenith, Karin
    de Haan, Lolke
    van Berkel, Patrick H.
    Sebire, Neil
    Ogunbiyi, Olumide K.
    Booth, Claire
    Gaspar, H. Bobby
    Thrasher, Adrian J.
    Chester, Kerry A.
    Amrolia, Persis J.
    [J]. MOLECULAR THERAPY, 2024, 32 (06) : 1672 - 1686
  • [3] A Depleting Anti-CD45 Monoclonal Antibody as Isolated Conditioning for Bone Marrow Transplantation in the Rat
    Jaeger, Mark D.
    Vondran, Florian W. R.
    Ramackers, Wolf
    Roeseler, Tilmann
    Schlitt, Hans J.
    Bektas, Hueseyin
    Klempnauer, Juergen
    Timrott, Kai
    [J]. PLOS ONE, 2016, 11 (05):
  • [4] Antibody-Drug Conjugates: A Review on the Epitome of Targeted Anti-Cancer Therapy
    Hasan, Mahmudul
    Alam, Safaet
    Poddar, Saikat Kumar
    [J]. CURRENT CLINICAL PHARMACOLOGY, 2018, 13 (04): : 236 - 251
  • [5] Clearing and replacing tissue-resident myeloid cells with an anti-CD45 antibody-drug conjugate
    Gustafsson, Karin
    Rhee, Catherine
    Frodermann, Vanessa
    Scadden, Elizabeth W.
    Li, Dan
    Iwamoto, Yoshiko
    Palchaudhuri, Rahul
    Hyzy, Sharon L.
    Boitano, Anthony E.
    Nahrendorf, Matthias
    Scadden, David T.
    [J]. BLOOD ADVANCES, 2023, 7 (22) : 6964 - 6973
  • [6] Optimal preloading in radioimmuno-therapy with anti-CD45 antibody
    Kletting, P.
    Reske, S. N.
    Glatting, G.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 : S238 - S238
  • [7] Preclinical evaluation of anti-CD269 antibody-drug conjugates
    Palfi, A.
    Kulke, M.
    Mueller, C.
    Lutz, C.
    Pahl, A.
    Hechler, T.
    [J]. EUROPEAN JOURNAL OF CANCER, 2016, 69 : S24 - S24
  • [8] Anti-RON antibody-drug maytansinoid conjugates (Anti-RON ADC) as potential biotherapeutics for targeted colorectal cancer therapy
    Wang, Ming-Hai
    Feng, Liang
    Yao, Hang-Ping
    Wang, Wei
    Sharma, Sharad
    Zhang, Ruiwen
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [9] I-131 anti-CD45 antibody as a part of a conditioning regimen prior to bone marrow transplantation acute leukemia.
    Eary, JF
    Matthews, DC
    Appelbaum, FR
    Mitchell, DA
    Bernstein, ID
    [J]. JOURNAL OF NUCLEAR MEDICINE, 1996, 37 (05) : 1052 - 1052
  • [10] Preclinical evaluation of anti-RON antibody-drug maytansinoid conjugates (anti-RON ADC) for targeted colorectal cacner therapy.
    Feng, Liang
    Yao, Hang-Ping
    Wang, Wei
    Sharma, Sharad
    Zhang, Ruiwen
    Wang, Ming-Hai
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
12345